SciELO - Scientific Electronic Library Online

 
vol.24 número1Reconstrucción de la evolución molecular de la infección actual por el virus linfotrópico humano tipo I en ColombiaAspectos toxinológicos e inmunoquímicos del veneno del escorpión Tityus pachyurus Pocock de Colombia: capacidad neutralizante de antivenenos producidos en Latinoamérica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Biomédica

versión impresa ISSN 0120-4157versión On-line ISSN 2590-7379

Resumen

ORDONEZ, Leonardo Elías  y  ANGULO, Esther Sofía. Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis. Biomédica [online]. 2004, vol.24, n.1, pp.33-41. ISSN 0120-4157.

In a small village of Amazonian Coombia, the efficacy of ivermectin (200 µg/kg/day) was determined in a two-day treatment of children with uncomplicated strongyloidiasis. Criteria for inclusion in the study were as follows: absence of acute disease, no pretreatment with antiparasitic drugs within the last month, absence of severe liver or neurological disorders, and at least 2 of 4 stool samples positive for Strongyloides stercoralis. The Baermann technique was used to detect larvae; it had the advantage of reducing the frequency of false negative results in the subsequent examinations. Of 60 potential subjects, 49 fulfilled the above criteria. The cure rate for the S. stercoralis infection was 94% (46/49), with slight and temporary side effects. The effects of ivermectin on other intestinal parasites were characterized as well. In conclusion, a 200 µg/kg/d ivermectin dose was an adequate therapeutic regimen in the treatment of uncomplicated strongyloidiasis in children.

Palabras clave : Strongyloides stercoralis; strongyloidiasis; ivermectin; intestinal parasites.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons